139 related articles for article (PubMed ID: 6064878)
1. Effect of aggregating agents on platelet electrophoretic mobility.
Hampton JR; Mitchell JR
Thromb Diath Haemorrh Suppl; 1967; 26():69-70. PubMed ID: 6064878
[No Abstract] [Full Text] [Related]
2. Studies on ADP-induced platelet aggregation in normal and diseased groups.
Yamakido M; Oishi N; Yokoyama M
Hawaii Med J; 1970; 29(6):446-9. PubMed ID: 5503441
[No Abstract] [Full Text] [Related]
3. Studies on lipid peroxides in platelets. II. Effect of aggregating agents and platelet antibody.
Okuma M; Steiner M; Baldini G
J Lab Clin Med; 1971 May; 77(5):728-42. PubMed ID: 5557659
[No Abstract] [Full Text] [Related]
4. A comparison of platelet stickiness tests during an atromid-S trial.
O'Brien JR; Heywood JB
Thromb Diath Haemorrh; 1966 Dec; 16(3):768-77. PubMed ID: 5996687
[No Abstract] [Full Text] [Related]
5. Effects of N-(2-diethylaminoethyl)-N-(2-hydroxy-2-phenylethyl)-2,5-dichloroaniline (AN162) on platelet function and blood coagulation.
Mac Kenzie RD; Blohm TR
Thromb Diath Haemorrh; 1971 Dec; 26(3):577-87. PubMed ID: 5004226
[No Abstract] [Full Text] [Related]
6. Bleeding tendency associated with "new" abnormality of platelet behaviour.
Hardisty RM; Hutton RA
Lancet; 1967 May; 1(7497):983-5. PubMed ID: 4164609
[No Abstract] [Full Text] [Related]
7. [Study of the platelet electrophoretic mobility and the microcirculation under the influence of different substances (ADP, ATP, noradrenaline). Attempt to correlate the aggregating (and disaggreating) capacity and the zeta potential].
Larcan A; Stoltz JF; Stoltz M; Peters A
C R Seances Soc Biol Fil; 1968 Jul; 162(1):204-9. PubMed ID: 4236010
[No Abstract] [Full Text] [Related]
8. Effects of adenosine diphosphate and adrenaline on mean platelet shape.
O'Brien JR
Nature; 1965 Jul; 207(994):306-7. PubMed ID: 5886232
[No Abstract] [Full Text] [Related]
9. ADP- and collagen-induced platelet aggregation in vivo and in vitro.
Zucker MB
Thromb Diath Haemorrh Suppl; 1967; 26():175-84. PubMed ID: 4863690
[No Abstract] [Full Text] [Related]
10. The quantitation of platelet aggregation induced by four compounds: a study in relation to myocardial infarction.
O'Brien JR; Heywood JB; Heady JA
Thromb Diath Haemorrh; 1966 Dec; 16(3):752-67. PubMed ID: 5998919
[No Abstract] [Full Text] [Related]
11. Effect of pyrimido-pyrimidine compounds on platelet function.
Cucuianu MP; Nishizawa EE; Mustard JF
J Lab Clin Med; 1971 Jun; 77(6):958-74. PubMed ID: 5559863
[No Abstract] [Full Text] [Related]
12. Effect of phentolamine, an alpha receptor blocking agent, on epinephrine, ADP and collagen induced factor 4 release and platelet aggregation.
Kubisz P; Levy-Toledano S; Cronberg S; Pinkhas J; Caen J
Rev Eur Etud Clin Biol; 1970 Apr; 15(4):429-32. PubMed ID: 4393725
[No Abstract] [Full Text] [Related]
13. Influence of fibrinogen on the aggregation of washed human blood platelets induced by adenosine diphosphate, thrombin, collagen, and adrenaline.
Solum NO; Stormorken H
Scand J Clin Lab Invest; 1965; 17():Suppl 84:170+. PubMed ID: 5862557
[No Abstract] [Full Text] [Related]
14. Influence of aggregating agents on electrophoretic mobility of blood platelets from health individuals and from patients with cardiovascular diseases.
Gröttum KA
Lancet; 1968 Jun; 1(7557):1406-8. PubMed ID: 4172993
[No Abstract] [Full Text] [Related]
15. [Effect of drugs on blood platelet characteristics].
Zbinden G
Schweiz Med Wochenschr; 1971 Nov; 101(46):1658-62. PubMed ID: 5140632
[No Abstract] [Full Text] [Related]
16. Hemodynamic changes of adenosine diphosphate, adenosine triphosphate, and thrombin in relation to their platelet-aggregating activity.
Swedenborg J; Taylor G; Olsson P
Scand J Clin Lab Invest; 1971 May; 27(3):213-9. PubMed ID: 5581182
[No Abstract] [Full Text] [Related]
17. The effect of resveratrol on the platelet secretory process induced by endotoxin and thrombin.
Olas B; Wachowicz B; Szewczuk J; Saluk-Juszczak J; Kaca W
Microbios; 2001; 105(410):7-13. PubMed ID: 11368092
[TBL] [Abstract][Full Text] [Related]
18. Platelet-platelet interaction: relationship to hemostasis and thrombosis.
Rodman NF; Mason RG
Fed Proc; 1967; 26(1):95-105. PubMed ID: 6018930
[No Abstract] [Full Text] [Related]
19. Absent plasma second phase platelet aggregation factor in a patient with Hageman trait.
Okonkwo P; Post R; Sise H
Thromb Diath Haemorrh; 1970 Jun; 23(3):423-31. PubMed ID: 5432187
[No Abstract] [Full Text] [Related]
20. Blood cell aggregation and biological agents.
Swank RL; Fellman JH
Bibl Anat; 1967; 9():98-103. PubMed ID: 6029913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
